NanoPass Technologies to Supply MicronJet™ Device to Immune Design for Use in ZVex-based Oncology Immunotherapy Productsmonimono2020-06-03T04:27:51+00:00September 8th, 2015|Read More
NanoPass Technologies will Present 8 Years of Clinical Experience With Its MicronJet™ Devicemonimono2020-06-03T04:28:57+00:00August 31st, 2015|Read More
Circassia and NanoPass strike up deal over intradermal devicemonimono2020-06-03T04:31:06+00:00September 19th, 2011|Read More